İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Akademisyen

VİLDAN ÖZKOCAMAN

PROFESÖR

BURSA ULUDAĞ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Araştırma konuları OpenAlex
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 157
YÖKSİS157 OpenAlex0
Proje 3
Kitap 8
Bildiri 121

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 16
h-indeks 6 Türkiye yüzdelik dilimi: 72 Üniversitesinde h-indekse göre 151. / 866
i10-indeks
4
Toplam atıf
93
Türkiye’de üst %34
Makale başına
5,8
FWCI
1,67
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
2

En çok atıf alan makaleleri

  1. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia 2020 19 atıf
  2. Long term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience 2020 dünyada üst %10 15 atıf
  3. A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia 2019 15 atıf

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 69
  • Q1 23
  • Q2 24
  • Q3 16
  • Q4 6
WoS (JCR) 69
  • Q1 16
  • Q2 16
  • Q3 22
  • Q4 15
TR Index TR Index

50 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 2
  • Ort. 53.4%
  • n 16
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 67 Q1 21 Q2 24 Q3 16 Q4 6
  • YÖKSİS satırı 73

WoS (JCR)

  • Özet hariç 67 Q1 14 Q2 16 Q3 22 Q4 15
  • YÖKSİS satırı 73

TR Index

  • YÖKSİS satırı 55 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

71 dergi
Scopus (SJR)
Q1 23 Q2 24 Q3 16 Q4 6
WoS (JCR)
Q1 16 Q2 16 Q3 22 Q4 15
TR Index
50 makale

Makale listesi

  1. 2026 Comparative Evaluation of Single-Dose and Split-Dose Melphalan Conditioning Concerning Toxicity Profiles and Engraftment Kinetics: A Propensity Score-Matched Analysis Transplantation and Cellular Therapy DOI 10.1016/J.JTCT.2026.05.044 YÖKSİS SJR Q1 JCR Q1
  2. 2026 Beyond the Thrombophilia Panel: Real-World Overuse, Limited Interpretability, and Poor Guideline Concordance in a Hematology Referral Cohort Diagnostics DOI 10.3390/diagnostics16162643 YÖKSİS SJR Q2 JCR Q1
  3. 2026 Management of Rituximab-Associated Hypersensitivity Reactions with Successfully Applied Desensitization Protocols: A Clinical Experience of 46 Infusions in 11 Patients Journal of Clinical Medicine DOI 10.3390/jcm15114164 YÖKSİS SJR Q2 JCR Q1
  4. 2026 Early Divergent Cardiac Adaptation After Hematopoietic Stem Cell Transplantation: A Multimodal Echocardiographic and Electrocardiographic Study Diagnostics DOI 10.3390/diagnostics16101423 YÖKSİS SJR Q2 JCR Q1
  5. 2026 Clinical outcomes and prognostic factors in hematologic malignancy patients with probable CMV pneumonia BMC Infectious Diseases DOI 10.1186/s12879-026-13708-6 YÖKSİS SJR Q1 JCR Q2
  6. 2026 Time-Dependent Prognostic Value of the mEASIX Score in Patients with Myelodysplastic Syndromes Diagnostics DOI 10.3390/diagnostics16111640 YÖKSİS SJR Q2 JCR Q1
  7. 2026 Antifungal Management in Patients with Hematologic Malignancies: From Primary Prophylaxis to Empirical and Diagnostic-Driven Treatment Turkish Journal of Haematology DOI 10.4274/tjh.galenos.2026.32559 YÖKSİS TR Index SJR Q3 JCR Q3
  8. 2026 Effect of fresh versus cryopreserved grafts on febrile neutropenia and Infections in allogeneic hematopoietic cell transplantation: Factors determining mortality Mediterranean Journal of Hematology and Infectious Diseases DOI 10.4084/MJHID.2026.032.eCollection YÖKSİS SJR Q3 JCR Q3
  9. 2026 The Dynamic Endothelial Activation and Stress Index (EASIX) as a Predictor of Early Death and Long-Term Survival in Acute Promyelocytic Leukemia (APL): A Multicenter Study Cancers DOI 10.3390/cancers18050843 YÖKSİS SJR Q1 JCR Q2
  10. 2026 Pre-Transplant Endothelial Activation and Stress Index (EASIX) and Albumin-Modified mEASIX (mEASIX_alb) Predict Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Medicina DOI 10.3390/medicina62081572 YÖKSİS SJR Q2 JCR Q1
  11. 2026 Defining a critical therapeutic window: cyclosporine exposure in months 1–2 as a determinant of acute graft-versus-host disease in patients with acute leukemia undergoing allogeneic hematopoietic stem cell transplantation from matched related donors Annals of Hematology DOI 10.1007/s00277-026-07131-9 YÖKSİS SJR Q2 JCR Q3
  12. 2026 Assessment of Treatment Response in Patients Diagnosed with Waldenström’s Macroglobulinemia: Single-Center Experience Uludağ Üniversitesi Tıp Fakültesi Dergisi DOI 10.32708/uutfd.1954370 YÖKSİS TR Index
  13. 2025 Antifungal Prophylaxis in Hypomethylating Agents Venetoclax Combination in AML-Turkish Society of Hematology Subcommittee on Infections and Supportive Therapies in Hematology Survey Study Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2024.2024.0436 YÖKSİS TR Index SJR Q3 JCR Q3
  14. 2025 Comparative Analysis and Validation of the IMPEDED VTE, IMPEDE VTE, and SAVED Risk Models in Predicting Venous Thromboembolism in Multiple Myeloma Patients: A Retrospective Study in Türkiye Diagnostics DOI https://www.mdpi.com/2075-4418/15/5/633/pdf YÖKSİS SJR Q2 JCR Q1
  15. 2025 Risk factors for mortality in febrile neutropenic patients treated with colistin Medicine DOI 10.1097/md.0000000000044841 YÖKSİS SJR Q2 JCR Q2
  16. 2025 Viable and Functional: Long-Term −80 °C Cryopreservation Sustains CD34+ Integrity and Transplant Success Journal of Clinical Medicine DOI 10.3390/JCM14197032 YÖKSİS
  17. 2025 Predicting Bleeding in AML-Associated DIC: Limitations of the ISTH Score and a Modified Approach Diagnostics DOI 10.3390/diagnostics15233053 YÖKSİS
  18. 2025 Prognostic Value of Inflammation and Nutrition-Based Scores in Low-Risk Myelodysplastic Syndrome: A Retrospective Cohort Study Journal of Clinical Medicine DOI 10.3390/jcm14134751 YÖKSİS
  19. 2025 A comparison of the effect of three different comorbidity indices on overall survival in patients with chronic myeloid leukemia Therapeutic Advances in Hematology DOI 10.1177/20406207251323701 YÖKSİS SJR Q1 JCR Q2
  20. 2025 Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy Diagnostics DOI 10.3390/diagnostics15020185 YÖKSİS SJR Q2 JCR Q1

Akademisyenlere dön